TY  - JOUR
AU  - Daza, Jorge
AU  - Gul, Zeynep
AU  - Sfakianos, John P.
PY  - 2019
TI  - Role of heat shock proteins in bladder cancer: potential biomarkers for treatment response and oncological prognosis
JF  - Translational Andrology and Urology; Vol 8, Supplement 3 (July 16, 2019): Translational Andrology and Urology
Y2  - 2019
KW  - 
N2  - Transurethral resection of bladder tumor (TURBT) and BCG intravesical instillation have been the gold standard for non-muscle invasive bladder cancer (NMIBC) treatment in patients with intermediate and high-risk disease (1,2). However, patients with T1 high grade (T1HG) disease still have relatively poor outcomes with 11.4 and 19.8% of patients experiencing disease progression at 1 and 5 years, respectively and disease specific mortality rates of 4.8% and 11.2%, respectively (3). The identification of biomarkers that could appropriately select patients who will benefit from BCG therapy would be greatly beneficial for optimizing outcomes and minimizing overtreatment.
UR  - https://tau.amegroups.org/article/view/23991